First CRISPR trial in humans will attempt to battle lung cancer

The first human trial of cells that have been tweaked by the genome-editing technique CRISPR will begin in China in August, Nature reports. The group will take white blood cells, which are part of the immune system, from people with a type of lung cancer and edit them using the CRISPR technology so they hunt cancer. Then, the lab-altered cells will be infused back into the patients.
The approach is similar to another trial in the U.S., which will test edited immune cells in several kinds of canc